The 2026 Chen et al. study tested calcium hydroxylapatite filler, a biostimulator that supports collagen growth, plus CO2 ablative fractional laser for depressed atrophic acne scars. It studied 160 adults ages 18–60 with facial atrophic scars, and it did not study pregnant people, recent filler or facial-procedure patients, or people with keloid tendency.
If you have indented scars, this study profile helps you judge fit. Compare your age, scar type, and recent treatments to the studied group. A clinician still must screen you in person.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 combination study tested
- Who qualified for the study
- Who was excluded and why it matters
- Scar types and off-label status
- What to do before you seek treatment
What the 2026 combination study tested
Springer Nature reports that Chen et al. published a 2026 randomized controlled study in Aesthetic Plastic Surgery on calcium hydroxylapatite plus CO2 ablative fractional laser for atrophic acne scars study page. The design compared an observation group A with a control group B.
The trial enrolled 160 participants at Deyi Skin/Dexi medical aesthetic clinic from December 2023 to March 2025. Staff randomly assigned each participant to group A or group B. As a single-center prospective study, it reflects one clinic and one adult patient type.
Who qualified for the study
Included participants were adults ages 18–60 with clinically diagnosed facial atrophic acne scars. They could comply with treatment and follow-up and had complete protocol data.
Check your fit against the studied group: If you fall outside this profile, the results do not directly describe you. A different age, scar location, or care setting needs separate evidence.
- age 18–60
- facial atrophic scars diagnosed by a clinician
- able to attend treatment and follow-up visits
- complete records for the study protocol
Who was excluded and why it matters
Excluded people had a facial cosmetic procedure within 3 months or filler injections within 6 months. Excluded groups also included pregnancy or lactation, agent allergy or photosensitivity, and keloid or hypertrophic-scar tendency.
These exclusions were not listed for review: These factors can change healing, scarring risk, or laser safety. If any apply to you, tell the clinic before discussing this combination.
- recent facial procedure within 3 months
- filler injection within 6 months
- pregnancy or lactation
- allergy to a study agent or photosensitivity
- tendency to keloids or thick raised scars
Scar types and off-label status
Dermatology Times describes atrophic scars as depressed scars with three subtypes — icepick, boxcar, and rolling — where successful treatment depends on stimulating collagen production scar overview. Icepick scars are narrow and deep, boxcar scars have sharper edges, and rolling scars look wavy. Your subtype affects which approach a clinician may consider.
Merz Aesthetics lists Radiesse calcium hydroxylapatite as a biostimulator for immediate correction plus longer-term collagen and elastin stimulation, with FDA-cleared uses for facial wrinkles and folds, hand volume loss, jawline contour, and décolleté wrinkles product notice. Those cleared uses do not include acne scars, so scar use is off-label and investigational. That status means coverage, consent, and follow-up differ from approved uses.
What to do before you seek treatment
Use the study limits as a screening guide, not a recommendation. Results apply most directly to similar adult facial atrophic-scar patients seen in a similar clinic.
Other ages, body areas, scar types, and health histories need separate screening and evidence. Bring a clear history to a consultation: Ask whether the clinic treats your scar subtype and exclusion profile and what off-label consent involves. Bring photos of your scars in plain daylight for the first visit.
- scar onset, location, and prior diagnosis
- cosmetic procedures and fillers with dates
- pregnancy, allergy, light sensitivity, and keloid history
- current skin care, sun exposure, and healing problems
You Might Also Like
- The 33-Patient RF Microneedling vs CO2 Acne Scar Trial in 2026: Who Was Studied and Who Was Not for People With Atrophic Acne Scars
- Radiofrequency Microneedling vs Fractional CO2 for Acne Scars in 2026: Who Was Studied and Who Was Not for People With Atrophic Acne Scars
- Recovery and Pigment Safety in the 2026 Split-Face Acne Scar Trial: Who Was Studied and Who Was Not for People With Icepick Acne Scars